Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by gebremeskelon Jan 19, 2025 10:42pm
174 Views
Post# 36411390

RE:RE:For new investors...

RE:RE:For new investors...LOL So speaks one of our resident red-nosed clowns! He is a member of a small clique of bashers who have infested this board for many years. This particular soft basher has been trying to come off as a "realistic" shareholder for some time now. Be on your guard newbies - he has succeeded in fooling some otherwise sensible posters.

N0taP00p wrote: If anyone invests based on message board posts, just know this.  There's an over the top group of excitable investors here (you'll know them from their always-on praise of TLT management and a cult-like adoration of every schedule delay and share dilution at pennies on the dollar). They've been with us long suffering investors and primarily provide entertainment. There's a 20 point list for why it's a good thing if the CEO sneezes on a Friday while slipping in news of the latest delay.     After a dozen plus years of waiting, it's clear TLT is circling the drain if they don't figure out how to raise money in a better way and stick to schedules.  They need to get BTD in Q1.  Don't mix it up with anything else. BTD in Q1 for BCG -resistant NMIBC.  Full stop.   
wildbird1 wrote: For information purpose....

Here is what I consider TLT management two best achievements since day one.

Number 1 best achievement.
- Definitively teaming up with that first-class genious Dr Sherri McFarland.
She didn't stop with creating TLD-1433.
No! She kept on searching for better PDC, as stipulated in this 2017 link...
Theralase® Researcher Discovers Super Potent Anti-Cancer Drugs – Theralase Technologies

'' Theralase researcher(Dr McFarland) discovers new super potent anti-cancer drug, 10 billion time more potent in killing cancer cells than other tested PDC... and according to Dr McFarland it has a very low toxicity level.

Two questions.
Question 1-What would happen if you combine this new super PDC with Metformin, a safe generic(free for commercial use) diabetic drug that can activate PDC anywhere in the body without the need for light?

Question 2-How much$ would a Big Pharma be willing to pay for such a powerful PDC compound.
Note: Why haven't we heard more about that super PDC compound?
It takes many years of testing and a lot of money to prove that a new compound is safe for testing on human.
As we speak TLT management is giving priority to the FDA BTD approval of TLD-1433.
But once TLD-1433  get BTD approval and a Big Pharma  joint-venture $deal, WATCH OUT. 

Number 2 best achievement.
I love repeating this next one(and will continue to do so).

-The unsurpassed data and Duration Of Response of Ruvidar, that brought on the backing of the Scientific Community, as stipulated in Eoganacht 2 articles.
'' Today's TLD-1433 shout out'' (1 and 2).

The backing of the Scientific Community is a very trustworthy signal indicating that the FDA approval of TLD-1433 is just a question of time.
$Note: A Big Pharma negotiating a JV deal with TLT will certainly know about Dr McFarland super PDC, and it could increase big time the $value of a Big Pharma deal.

To new investors, buy and hold, because after the FDA approval of TLD-1433, things could evolve much faster.

I love TLT management.
And I love my TLT shares.





<< Previous
Bullboard Posts
Next >>